2013
DOI: 10.1007/s10719-013-9514-6
|View full text |Cite
|
Sign up to set email alerts
|

Effects of sesamin on the biosynthesis of chondroitin sulfate proteoglycans in human articular chondrocytes in primary culture

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
10
1

Year Published

2017
2017
2023
2023

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 15 publications
(12 citation statements)
references
References 40 publications
1
10
1
Order By: Relevance
“…The highest CSPGs gene expression in normal HAC was on day 14, while in IL-1β induced HAC, the highest expression of CHSY1 and ChPF was on day 7, while for ACAN, XT-1 and XT-2 it was on day 14 which differs from a previous study [9]. The difference of CSPGs expression pattern in IL-1β-induced HAC may have been due to chondrocyte compensatory mechanisms which counter IL-1β action [23].…”
Section: Discussioncontrasting
confidence: 99%
See 3 more Smart Citations
“…The highest CSPGs gene expression in normal HAC was on day 14, while in IL-1β induced HAC, the highest expression of CHSY1 and ChPF was on day 7, while for ACAN, XT-1 and XT-2 it was on day 14 which differs from a previous study [9]. The difference of CSPGs expression pattern in IL-1β-induced HAC may have been due to chondrocyte compensatory mechanisms which counter IL-1β action [23].…”
Section: Discussioncontrasting
confidence: 99%
“…Sesamin has previously demonstrated regulation of the chondrocyte catabolic process via suppression of expression of MMPs through the inhibition of IL-1β signaling cascades [4]. It has also shown induction on CSPGs proteoglycan synthesis via enhancement of chondrocyte CSPGs synthetic genes [9]. …”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…[19] MSC and chondrocytes grown in 3D cell aggregates are capable to produce a cartilaginous matrix, similar to native tissue, [17,20] and provide a simple tool to screen new drugs for articular disorders, like OA. [21] Bhumiratana et al took these simple 3D models a step further by fusing several cell aggregates (condensed mesenchymal cell bodies (CMBs)), to form a cartilage-like layer in an in vitro model using bone decellularized ECM, and to fill a cartilage defect in an ex vivo cartilage explant model. CMBs formed cartilage like-tissue, with glycosaminoglycans (GAGs) and type II collagen (COL2) production, and integrated in the decellularized bone or native cartilage explants, indicating that this methodology has the potential to create implantable solutions to repair cartilage defects.…”
Section: From Basic To Advanced Cartilage Models: New Strategies To Dmentioning
confidence: 99%